Details of the Drug

General Information of Drug (ID: DMY89BN)

Drug Name

URC102

Indication

Disease Entry	ICD 11	Status	REF
Gout	FA25	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT02290210) Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Chugai Pharmaceutical (2013).